Skip to main content
. 2015 Jul 17;6(28):26266–26277. doi: 10.18632/oncotarget.4656

Figure 5. Inhibition of CDK1 protects HCC cells from FQIs-induced G2/M arrest.

Figure 5

A. Western blot analysis of CyclinB1 and EF1α in the indicated cells upon 2 h pre-treatment with Roscovitine (Rosc) followed by treatment with FQI1 or FQI2. B. Representative cell cycle histograms of the indicated cells upon 2 h pre-treatment with Roscovitine (Rosc) followed by treatment with FQI1 or FQI2.